Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies
JP Le Couedic(Institut Gustave Roussy), William Vainchenker(Inserm)
Cited by 80
Related Papers
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
|Blood|2009|270
Clonal architecture of chronic myelomonocytic leukemias
|Blood|2013|268